drugset / Trial / NCT00822263

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

NCT00822263 ↗

Completed 150 enrolled Brooke Army Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The administration of N-acetyl-cysteine (an anti-oxidant) for seven days along with observation will result in improved hearing and balance function in individuals who demonstrate these disorders after blast exposure when compared to a placebo medicine and observation at the seven day time point.

Timeline

Start
2008-11
Primary completion
2009-03
Completion
2009-08

Outcome

Met primary endpoint

paper Logistic regression on the outcome of 'no day 7 symptoms' indicated that NAC treatment was significantly better than placebo (OR = 3.6, p = 0.006). PMID 23372680 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule — —